Dabrafenib,Trametinib
Novartis
['lymphoma', 'leukemia']
hairy cell leukemia #hclsm for the win! 89% response. interestingly, only 91% of hcl patients in the trial were confirmed braf v600e positive. wonder if the other 9% were non-hcl such as the new who classification splenic b-cell lymphoma/leukaemia with prominent nucleoli #aacr23 
Assistant Professor, UM Sylvester Comprehensive Cancer Center. Physician scientist studying the role of nuclear export and splicing in hematologic cancers.